Table 3.
Cox Models for BC-P4P Enrollment and Other Factors Related to Survival and Recurrence
Characteristic | 5-Year Overall Survival |
5-Year Recurrence |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Model 1 |
Model 2 |
Model 3 |
Model 4 |
|||||||||
Exp (β) | 95% CI | P | Exp (β) | 95% CI | P | Exp (β) | 95% CI | P | Exp (β) | 95% CI | P | |
Age | 1.012 | 1.002 to 1.021 | .019 | 1.010 | 1.000 to 1.019 | .045 | 0.983 | 0.976 to 0.990 | < .001 | 0.982 | 0.975 to 0.989 | < .001 |
Stage II (stage I, reference) | 2.562 | 1.947 to 3.371 | < .001 | 2.354 | 1.783 to 3.108 | < .001 | 1.801 | 1.522 to 2.130 | < .001 | 1.697 | 1.432 to 2.012 | < .001 |
Comorbidity | 1.885 | 1.608 to 2.211 | < .001 | 1.856 | 1.579 to 2.182 | < .001 | 1.478 | 1.266 to 1.724 | < .001 | 1.436 | 1.229 to 1.677 | < .001 |
Margin free | 0.719 | 0.465 to 1.114 | .140 | 0.820 | 0.525 to 1.279 | .382 | 0.652 | 0.494 to 0.861 | .003 | 0.717 | 0.540 to 0.952 | .021 |
Breast-conserving surgery | 0.903 | 0.698 to 1.168 | .437 | 1.106 | 0.829 to 1.474 | .495 | 1.087 | 0.924 to 1.280 | .314 | 1.289 | 1.067 to 1.557 | .008 |
Public hospital | 0.990 | 0.781 to 1.254 | .931 | 1.282 | 0.995 to 1.653 | .055 | 0.862 | 0.729 to 1.020 | .084 | 1.010 | 0.843 to 1.210 | .912 |
Medical school–affiliated hospital | 0.896 | 0.722 to 1.112 | .320 | 0.711 | 0.561 to 0.901 | .005 | 0.956 | 0.824 to 1.108 | .548 | 0.831 | 0.704 to 0.982 | .030 |
Surgeon volume | 0.999 | 0.996 to 1.003 | .737 | 1.000 | 0.997 to 1.002 | .658 | ||||||
Quality of care | 0.212 | 0.089 to 0.502 | < .001 | 0.289 | 0.162 to 0.516 | < .001 | ||||||
BC-P4P enrollment | 0.167 | 0.064 to 0.432 | < .001 | 0.370 | 0.200 to 0.685 | .002 | ||||||
Interaction of surgeon volume and quality of care | 1.001 | 0.996 to 1.006 | .727 | 1.001 | 0.998 to 1.004 | .480 | ||||||
Interaction of BC-P4P and quality of care | 7.016 | 1.855 to 26.530 | .004 | 3.183 | 1.393 to 7.274 | .006 | ||||||
Propensity score | 0.989 | 0.474 to 2.064 | .976 | 0.716 | 0.428 to 1.199 | .204 |
Abbreviation: BC-P4P, pay-for-performance program for breast cancer care.